Lv31
300 积分 2024-07-23 加入
338 Randomized Phase Ill Study of Watchful Waiting Vs.Rituximab As First-Line Treatment in Patients with Advanced Stage Low Tumor Burden Follicular Lymphoma:JCOG1411/Flora Study
5天前
已完结
Randomized Phase III Study of Watchful Waiting Vs. Rituximab As First-Line Treatment in Patients with Advanced Stage Low Tumor Burden Follicular Lymphoma: JCOG1411/Flora Study
5天前
已关闭
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
15天前
已完结
MRD-guided zanubrutinib, venetoclax and obinutuzumab in relapsed CLL: primary endpoint analysis from the CLL2-BZAG trial
1个月前
已完结
Diagnosis and Treatment of Polycythemia Vera
1个月前
已完结
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium
2个月前
已完结
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients
2个月前
已关闭
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients
2个月前
已关闭
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management
2个月前
已完结
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium
3个月前
已完结
皖公网安备34019202002308
